These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1690277)

  • 1. Immune response and epitope mapping of a candidate HIV-1 p17 vaccine HGP30.
    Boucher CA; Krone WJ; Goudsmit J; Meloen RH; Naylor PH; Goldstein AL; Sun DK; Sarin PS
    J Clin Lab Anal; 1990; 4(1):43-7. PubMed ID: 1690277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection.
    Jiang JD; Chu FN; Naylor PH; Kirkley JE; Mandeli J; Wallace JI; Sarin PS; Goldstein AL; Holland JF; Bekesi JG
    J Acquir Immune Defic Syndr (1988); 1992; 5(4):382-90. PubMed ID: 1372353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 p17 synthetic peptide vaccine HGP-30: induction of immune response in human subjects and preliminary evidence of protection against HIV challenge in SCID mice.
    Sarin PS; Mora CA; Naylor PH; Markham R; Schwartz D; Kahn J; Heseltine P; Gazzard B; Youle M; Rios A
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):401-7. PubMed ID: 7580834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS.
    Fiorentini S; Giagulli C; Caccuri F; Magiera AK; Caruso A
    Pharmacol Ther; 2010 Dec; 128(3):433-44. PubMed ID: 20816696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
    Fiorentini S; Marini E; Bozzo L; Trainini L; Saadoune L; Avolio M; Pontillo A; Bonfanti C; Sarmientos P; Caruso A
    Biopolymers; 2004; 76(4):334-43. PubMed ID: 15386266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-clade p17 peptide recognition by antisera to HGP-30, a 30-amino acid synthetic peptide antigen from HIV type 1 p17.
    Zimmerman DH; Ulrich JT; Wright C; Lloyd JP; Winship MD; Sarin PS
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):741-9. PubMed ID: 9643374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I study of HGP-30, a 30 amino acid subunit of the human immunodeficiency virus (HIV) p17 synthetic peptide analogue sub-unit vaccine in seronegative subjects.
    Kahn JO; Stites DP; Scillian J; Murcar N; Stryker R; Volberding PA; Naylor PH; Goldstein AL; Sarin PS; Simmon VF
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1321-5. PubMed ID: 1466950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodominant epitopes of HIV-1 p17 and p24.
    Graham S; Follett EA; Wallace L; Desselberger U; Marsden HS
    AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1781-8. PubMed ID: 1280955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30.
    Naylor PH; Naylor CW; Badamchian M; Wada S; Goldstein AL; Wang SS; Sun DK; Thornton AH; Sarin PS
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2951-5. PubMed ID: 2437588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals.
    Achour A; Picard O; Zagury D; Sarin PS; Gallo RC; Naylor PH; Goldstein AL
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7045-9. PubMed ID: 1698289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection.
    Mehta SU; Rupprecht KR; Hunt JC; Kramer DE; McRae BJ; Allen RG; Dawson GJ; Devare SG
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):443-54. PubMed ID: 1692727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine--HGP-30-KLH.
    Naylor PH; Sztein MB; Wada S; Maurer S; Holterman D; Kirkley JE; Naylor CW; Zook BC; Hitzelberg RA; Gibbs CJ
    Int J Immunopharmacol; 1991; 13 Suppl 1():117-27. PubMed ID: 1823903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three antigenic regions in p17 of human immunodeficiency virus type 1 (HIV-1) revealed by mouse monoclonal antibodies and human antibodies in HIV-1 carrier sera.
    Liu X; Ota A; Watanabe M; Ueda S; Saitoh A; Shinagawa H; Nakata A; Kurimura T; Wang X; Zhao Y
    Microbiol Immunol; 1995; 39(10):775-85. PubMed ID: 8577268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic peptide AT20 coupled to KLH elicits antibodies against a conserved conformational epitope from a major functional area of the HIV-1 matrix protein p17.
    Fiorentini S; Marsico S; Becker PD; Iaria ML; Bruno R; Guzmán CA; Caruso A
    Vaccine; 2008 Aug; 26(36):4758-65. PubMed ID: 18602957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study on correlation between the decrease in anti-P17 antibody level and progression to AIDS in asymptomatic carriers of HIV.
    Choudhury AM; Yamada O; Wakamiya N; Kurimura T
    Microbiol Immunol; 1992; 36(8):833-40. PubMed ID: 1474934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide.
    Ota A; Tanaka-Taya K; Ueda S
    Hybridoma; 1999 Apr; 18(2):149-57. PubMed ID: 10380014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates.
    Horal P; Svennerholm B; Jeansson S; Rymo L; Hall WW; Vahlne A
    J Virol; 1991 May; 65(5):2718-23. PubMed ID: 1707985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of monoclonal antibodies against the p17 core protein of the human immunodeficiency virus 1.
    Cogniaux J; De Schepper N; Blondiau ML; Cornet B; Horal P; Vahlne A
    J Immunol Methods; 1990 Apr; 128(2):165-75. PubMed ID: 1691236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus.
    Gnann JW; Schwimmbeck PL; Nelson JA; Truax AB; Oldstone MB
    J Infect Dis; 1987 Aug; 156(2):261-7. PubMed ID: 2439614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.